CIK 0000072444 · Accelerated filer<br>Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 591212264
- Phone
- (650) 550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- DEFC14A Other DEFC14A
- PRER14A Other PRER14A
- PRRN14A Other PRRN14A
- PREC14A Other PREC14A
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- PREC14A Other PREC14A
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 144 Insider Sale of Securities
- 25-NSE Other Notification of Removal from Listing
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- DEFA14A Proxy Proxy Materials
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
Page 2 of 12 · 235 filings